Corrigendum to "Considering human challenge trials for tuberculosis vaccine development" [Vaccine 40(2) (2022) 173-174]

Vaccine. 2022 Jun 23;40(29):3984. doi: 10.1016/j.vaccine.2022.05.058. Epub 2022 May 28.

Authors

Gavriel Kleinwaks¹, Virginia Schmit², Josh Morrison²

Affiliations

¹ 1Day Sooner, United States. Electronic address: communications@1daysooner.org.
² 1Day Sooner, United States.

PMID: 35641359
DOI: 10.1016/j.vaccine.2022.05.058

No abstract available

Publication types

Published Erratum